Måndag 24 November | 03:18:51 Europe / Stockholm

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-07-02 09:50:00

Alligator Bioscience announced that new data from its ongoing phase Ib/II OPTIMIZE-1 trial will be presented at the ESMO Gastrointestinal Cancers Congress 2025, taking place in Barcelona on 2–5 July.